Case Report: An "Immune-Cold" EGFR Mutant NSCLC With Strong PD-L1 Expression Shows Resistance to Chemo-Immunotherapy.

Zhao, Qian; Zhang, Xue; Ma, Qiang; Luo, Nuo; Liu, Zhulin; Wang, Renyuan; He, Yong; Li, Li

Zhao, Qian; Zhang, Xue; Ma, Qiang; Luo, Nuo; Liu, Zhulin; Wang, Renyuan; He, Yong; Li, Li.

Affiliation

Zhao Q; Department of Respiratory Disease, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Zhang X; Department of Respiratory Disease, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Ma Q; Department of Pathology, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Luo N; Department of Respiratory Disease, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Liu Z; Department of Respiratory Disease, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Wang R; Department of Respiratory Disease, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
He Y; Department of Respiratory Disease, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Li L; Department of Respiratory Disease, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

Front Oncol ; 12: 765997, 2022.

Article in En | MEDLINE | ID: mdl-35273908

Key words

EGFR; case report; chemo-immunotherapy; resistance; tumor microenvironment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google